$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed instructions on the correct method and timing of taking Roaccutane (isotretinoin) soft capsules
2026-02-01 22:25:32
Check Details
Is Doxorubicin the same as doxorubicin? Comparative analysis of similarities, differences and clinical applications between the two
2026-02-01 22:25:32
Check Details
Is Everolimus covered by medical insurance? Analysis of medical insurance policy and reimbursement process
2026-02-01 22:25:32
Check Details
The maximum taking time and dosage limit of estramustine phosphate (Adelox) in a month
2026-02-01 22:25:32
Check Details
Detailed scientific explanation of the mechanism of action and treatment principle of Seripparase (BRINEURA)
2026-02-01 22:25:32
Check Details
Is Eslicarbazepine suitable for long-term use and analysis of drug safety
2026-02-01 22:25:32
Check Details
A detailed introduction to the main functions, efficacy and indications of Anagrelide
2026-02-01 22:25:32
Check Details
Detailed analysis of the mechanism of action and main effects of apalutamide (Ansenko)
2026-02-01 22:25:32
Check Details
Analysis of the reasons why the domestic launch of Elacetrant has been delayed many times
2026-02-01 22:25:32
Check Details
How much does a box of F/TAF cost and price comparison and reference of different purchase channels
2026-02-01 22:25:32
Check Details
How long does it take to take Febuxostat (Febuxostat) before you can safely stop taking it and what you need to pay attention to when stopping taking it
2026-02-01 22:25:32
Check Details
Furmonertinib belongs to which generation of targeted drugs and an introduction to its technical advantages
2026-02-01 22:25:32
Check Details
1
2
...
2128
2129
2130
2131
2132
2133
2134
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
2
From Causes to Treatments—Exploring Medical Breakthroughs
3
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
4
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
5
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
6
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
7
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
8
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
9
User Agreement
10
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
11
What is the most important information I should know about WELIREG?
12
How to take and store WELIREG